Article

A Novel, Uniquely Efficacious Type of CFTR Corrector with Complementary Mode of Action

medRxiv · 2023 · Marchesin, V.; Monnier, L.; Blattmann, P.; Chevillard, F.; Kuntz, C.; Forny, C.; Kamper, J.; Studer, R.; Bossu, A.; Ertel, E.; Nayler, O.; Brotschi, C.; Williams, J. T.; Gatfield, J.

Key facts

Title A Novel, Uniquely Efficacious Type of CFTR Corrector with Complementary Mode of Action
First author Marchesin, V.; Monnier, L.; Blattmann, P.; Chevillard, F.; Kuntz, C.; Forny, C.; Kamper, J.; Studer, R.; Bossu, A.; Ertel, E.; Nayler, O.; Brotschi, C.; Williams, J. T.; Gatfield, J.
Journal medRxiv
Published Aug 16, 2023
DOI 10.1101/2023.08.15.552928
Devices mentioned BK110039, DEN000008, K022086, K042152, K103302, K923652, K940422, K982100
Product codes mentioned CFN, DFZ, MFD, NDS, PCA, JCI, JJH, KIP, KIT, MVU, NJT, OOI

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature